Introduction
Mixed connective tissue disease (MCTD) is a rare autoimmune condition where the body’s immune system mistakenly attacks its tissue. It shares symptoms with lupus, scleroderma, and other similar diseases. While most people with MCTD know about its effects on the joints, skin, and muscles, many are unaware of the digestive problems that may be seen.1
In today’s article, we will explore how MCTD can affect the gastrointestinal tract and what are the potential symptoms of this condition.
How MCTD affects the digestive system
The digestive system can be affected, and this is because the ongoing inflammation in MCTD can affect the muscles and nerves that help move food through the digestive system, from the oesophagus to the intestines. When this system isn’t working as it should, several uncomfortable symptoms may appear.
Some people may experience difficulty swallowing, also known as dysphagia, and feel as though food has become lodged in their throat or chest. Heartburn and acid reflux are also common, causing a burning sensation after meals. Bloating and a feeling of fullness too soon after eating may occur due to slow stomach emptying. Changes in bowel habits, such as diarrhoea, constipation, or excessive gas, can disrupt daily routines. In more serious cases, poor absorption of nutrients may lead to unintentional weight loss and fatigue.2
Why do these symptoms happen?
Mixed connective tissue disease (MCTD) causes the immune system to mistakenly attack the body’s tissues, leading to inflammation and damage in various organs, including the digestive tract. The digestive system depends on smooth muscle movement and nerve coordination to push food from the mouth through to the intestines. When these muscles or nerves are affected by inflammation or scarring, the entire system can slow down or become uncoordinated.
In MCTD, the oesophagus, the tube that carries food from your throat to your stomach, is often one of the first areas affected. The muscles may weaken, making it harder to swallow or causing food to feel like it’s stuck. The valve between the oesophagus and the stomach may also not close properly, allowing stomach acid to flow back up, resulting in heartburn or acid reflux.3
As the disease progresses, the stomach and intestines can also be impacted. Inflammation and nerve damage may slow down the movement of food, leading to symptoms like bloating, nausea, and early satiety (feeling full after eating just a small amount). In the small intestine, slowed movement can allow bacteria to overgrow, interfering with digestion and nutrient absorption. Such inflammation can lead to diarrhoea, abdominal discomfort, and weight loss.
The colon, or large intestine, may also be affected, causing constipation or even a condition called pseudo-obstruction, where the bowel acts like there’s a blockage even though there isn’t one. These digestive symptoms aren’t just uncomfortable; if left untreated, they can lead to malnutrition and a significant decline in quality of life.
Understanding the root of these symptoms is important because it helps patients and doctors work together to manage the condition more effectively, improving both comfort and long-term health.
Tests that help find the cause
To evaluate and detect the cause of the matter, many tests can be done
Oesophagogastroduodenoscopy (EGD): A flexible endoscope allows direct visualisation of the oesophagus, stomach, and the beginning of the small intestine. This helps identify mucosal inflammation, ulceration, or structural abnormalities.4
Fluoroscopic swallowing studies (e.g., barium swallow or modified barium swallow): These radiographic tests observe the transit of a contrast agent through the oesophagus and upper digestive tract. They help detect dysmotility, aperistalsis, or impaired lower oesophageal sphincter function.
Oesophageal manometry and pH monitoring: Manometry measures pressures and peristalsis in the oesophagus, while pH studies assess gastro-oesophageal reflux. Both are important for diagnosing oesophageal dysmotility or persistent acid exposure.
Hydrogen breath tests or stool analyses: These non-invasive tests detect small intestinal bacterial overgrowth (SIBO) or malabsorption by measuring fermentation products or nutrient levels in stool.
How is it treated?
Although mixed connective tissue disease (MCTD) doesn’t yet have a cure, its gastrointestinal symptoms can often be managed effectively with the right approach. Treatment usually focuses on relieving discomfort, improving digestion, and controlling the underlying autoimmune process.
Doctors may start with medications, also known as pharmacologic therapy. These can include proton pump inhibitors (PPIs) or H2-receptor blockers to reduce stomach acid and ease heartburn or reflux. If there's an overgrowth of bacteria in the small intestine, a condition known as SIBO (small intestinal bacterial overgrowth), antibiotics may be prescribed. When gut movement is sluggish, prokinetic agents may help improve motility and reduce bloating or constipation or even some studies highlight the benefits of probiotics in the treatment of many gastrointestinal problems.5,6
In addition to medication, dietary adjustments can make a real difference. Eating smaller, more frequent meals, chewing slowly, and avoiding foods that trigger symptoms, such as spicy dishes, greasy foods, or carbonated drinks, can help reduce digestive strain.
Lifestyle changes are also important. Elevating the head of your bed can prevent acid reflux during the night, while quitting smoking and managing stress can reduce flare-ups and support overall digestive health.
In some cases, addressing the autoimmune component of MCTD directly can help. Immunosuppressive treatments such as corticosteroids or disease-modifying drugs may be used to calm the immune system and reduce inflammation that affects the gut. These treatments are carefully prescribed by your rheumatologist, based on your overall condition.
Living well with MCTD
Gastrointestinal symptoms can feel overwhelming at times, but with the right support, they don’t have to take over your life. A coordinated care team, often including a rheumatologist (who manages the autoimmune disease), a gastroenterologist (who focuses on digestive health), and a dietitian, can help you feel more in control of your symptoms.
Here are a few things you can do to take an active role in your care:
- Listen to your body. Don’t ignore new or changing symptoms, even small changes can be clues that something needs attention
- Track what you eat and how you feel. Keeping a simple food and symptom journal can help you and your doctor spot patterns and triggers
- Ask questions. Don’t hesitate to talk to your healthcare provider about the best treatment plan for you. Everyone's experience with MCTD is unique
Living with MCTD takes awareness, patience, and support, but with the right tools and team in place, many people find ways to live well and stay strong.
Summary
Mixed Connective Tissue Disease, or MCTD, is a rare autoimmune condition that can affect many parts of the body, including the digestive system. While people often associate MCTD with joint pain, skin issues, or fatigue, many also experience problems related to digestion. These may include difficulty swallowing, acid reflux, bloating, diarrhoea, or unintentional weight loss.
These symptoms happen because the immune system, which is supposed to protect you, mistakenly attacks the muscles and nerves that help your digestive tract work properly. This disrupts the normal movement of food and can make digestion uncomfortable or inefficient.
Although MCTD is a chronic condition with no cure, there are many ways to manage its digestive symptoms. With the right combination of medications, dietary and lifestyle changes, and regular support from your healthcare team, you can significantly improve your quality of life and stay on top of your health.
FAQs
What parts of the digestive system are affected by MCTD?
MCTD can affect the entire digestive tract, but the oesophagus is one of the most commonly involved areas. People often experience trouble swallowing or heartburn. Over time, the stomach, small intestine, and colon can also be affected, leading to issues like bloating, constipation, or diarrhoea.
Why do digestive symptoms happen in MCTD?
The inflammation caused by MCTD can damage the smooth muscles and nerves of the digestive system. This interferes with how food moves through the gut, how well nutrients are absorbed, and how stomach acid is managed.
Are these symptoms dangerous?
They can be if left untreated. Persistent digestive symptoms can lead to malnutrition, weight loss, or more serious complications like intestinal pseudo-obstruction. That’s why it’s important to talk to your doctor if you notice any changes in how your body digests food.
How are these symptoms diagnosed?
Doctors use a range of tests to understand what’s happening inside your digestive system. These may include endoscopy to look inside the oesophagus and stomach, manometry to check muscle movement, and breath or stool tests to detect infections or poor absorption.
Can digestive problems in MCTD be treated?
Yes, they can. Medications like acid reducers, antibiotics for bacterial overgrowth, or drugs that help with gut movement are often helpful. Adjusting your eating habits, such as eating smaller meals and avoiding trigger foods, can also ease symptoms. In some cases, treating the underlying immune system activity with immunosuppressants can improve digestive health too.
Will I always have these symptoms?
Symptoms may come and go. Some people experience long periods of stability, especially with consistent care. Regular check-ins with your doctor and a favourable treatment plan can make a big difference in how you feel day to day.
References
- Curraj E, Belkoniene M, Keutchakeu-Tchatcho C, Ringwald M, Ribi C. [Mixed connective tissue disease and its management]. Rev Med Suisse. 3 avr 2024;20(868):699‑704.
- Marshall JB, Kretschmar JM, Gerhardt DC, Winship DH, Winn D, Treadwell EL, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. mai 1990;98(5 Pt 1):1232‑8.
- Gutierrez F, Valenzuela JE, Ehresmann GR, Quismorio FP, Kitridou RC. Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus. Dig Dis Sci. juill 1982;27(7):592‑7.
- Thonhofer R, Siegel C, Trummer M, Graninger W. Early endoscopy in systemic sclerosis without gastrointestinal symptoms. Rheumatol Int. janv 2012;32(1):165‑8.
- Plehhova K, Paquette N, Gould J, Coyle C. Understanding the patient ppi journey: results of a survey on ppi treatment initiation and patient experience. J Prim Care Community Health. 2022;13:21501319221088688.
- Reznik E, Newberry C. Current treatment options for adult patients with short gut syndrome: Do prebiotics, probiotics, and synbiotics play a role? Nutr Clin Pract. 9 mai 2025;

